Omeros reported $123.43M in Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acelrx Pharmaceuticals ACRX:US $ 72.26M 7.32M
Adamas Pharmaceuticals ADMS:US 143.98M 6.67M
Adma Biologics ADMA:US $ 238.64M 5.83M
Aerie Pharmaceuticals AERI:US $ 351.8M 3.73M
Alexion Pharmaceuticals ALXN:US $ 18650.2M 547.2M
Alnylam Pharmaceuticals ALNY:US $ 3472.31M 37.12M
Biomarin Pharmaceutical BMRN:US $ 5977.48M 78.98M
Cytokinetics CYTK:US $ 827.54M 263.24M
Dynavax Technologies DVAX:US $ 919.71M 271.8M
Gilead Sciences GILD:US $ 67098M 886M
Heron Therapeutics HRTX:US $ 352.39M 51.86M
Insmed INSM:US $ 1.31B 81.99M
Intercept Pharmaceuticals ICPT:US $ 523.07M 0.15M
Knight Therapeutics Inc GUD:CN C$ 1.04B 6.03M
Macrogenics MGNX:US $ 392.16M 33.75M
Mirati Therapeutics MRTX:US $ 1253.43M 102.27M
Omeros OMER:US $ 123.43M 21.96M
Pacira Pharmaceuticals PCRX:US $ 1356M 30.17M
Sangamo Biosciences SGMO:US $ 772.4M 62.96M
Sarepta Therapeutics SRPT:US $ 2662.22M 96.86M
United Therapeutics UTHR:US $ 5048.9M 204M
Vertex Pharmaceuticals VRTX:US $ 12618.74M 397.06M
Vital Therapies VTL:US $ 156.76M 20.7M
Xoma XOMA:US $ 130.5M 5.25M